Expression of cancer stem cell markers ALDH1 and Bmi1 in oral erythroplakia and the risk of oral cancer

Journal of Oral Pathology and Medicine

Volumn 42, Issue 2, 2013, Pages 148-153

  Feng, Jin Qiu ^a   Xu, Zi Yuan ^b   Shi, Lin Jun ^c   Wu, Lan ^c   Liu, Wei ^c   Zhou, Zeng Tong ^c  

^a Shanghai Municipal Hospital for Oral Health   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

ALDH1; Bmi1; Dysplasia; Malignant transformation; Oral cancer; Oral erythroplakia

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; BMI1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MALE; MALIGNANT TRANSFORMATION; MOUTH CANCER; ORAL ERYTHROPLAKIA; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; COHORT STUDIES; ERYTHROPLASIA; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASTIC STEM CELLS; POLYCOMB REPRESSIVE COMPLEX 1; RETINAL DEHYDROGENASE; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TUMOR MARKERS, BIOLOGICAL; ZINC FINGERS;

EID: 84873274092     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2012.01191.x     Document Type: Article

References (28)

1. Zini A, Czerninski R, Sgan-Cohen HD. Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites. J Oral Pathol Med 2010; 39: 299-305.
2. Warnakulasuriya S. Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes that influence survival. Oral Oncol 2010; 46: 407-10.
3. Ganly I, Patel S, Shah J. Early stage squamous cell cancer of the oral tongue- clinicopathologic features affecting outcome. Cancer 2012; 118: 101-11.
4. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. Oral Oncol 2010; 46: 423-5.
5. Villa A, Villa C, Abati S. Oral cancer and oral erythroplakia: an update and implication for clinicians. Aust Dent J 2011; 56: 253-6.
6. Reichart PA, Philipsen HP. Oral erythroplakia: a review. Oral Oncol 2005; 41: 551-61.
7. Qin GZ, Park JY, Chen SY, Lazarus P. A high prevalence of p53 mutations in pre-malignant oral erythroplakia. Int J Cancer 1999; 80: 345-8.
8. Lingen MW, Pinto A, Mendes RA, et al.Genetics/epigenetics of oral premalignancy: current status and future research. Oral Dis 2011; 17(Suppl. 1): 7-22.
9. Zhang Z, Filho MS, Nör JE. The biology of head and neck cancer stem cells. Oral Oncol 2012; 48: 1-9.
10. Sayed SI, Dwivedi RC, Katna R, et al.Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer. Oral Oncol 2011; 47: 237-43.
11. Krishnamurthy S, Nör JE. Head and neck cancer stem cells. J Dent Res 2012; 91: 334-40.
12. Marcato P, Dean CA, Giacomantonio CA, Lee PW. Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle 2011; 10: 1378-84.
13. Kang MK, Kim RH, Kim SJ, et al.Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer 2007; 96: 126-33.
14. Yu CC, Lo WL, Chen YW, et al.Bmi-1 regulates snail expression and promotes metastasis ability in head and neck squamous cancer-derived ALDH1 positive cells. J Oncol 2011; 2011: 609259.
15. Chen YC, Chang CJ, Hsu HS, et al.Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1. Oral Oncol 2010; 46: 158-65.
16. Deng S, Yang X, Lassus H, et al.Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS ONE 2010; 5: e10277.
17. Chen C, Wei Y, Hummel M, et al.Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS ONE 2011; 6: e16466.
18. Clay MR, Tabor M, Owen JH, et al.Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck 2010; 32: 1195-201.
19. Sterz CM, Kulle C, Dakic B, et al.A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9. Oral Oncol 2010; 46: 116-22.
20. Chen YW, Chen KH, Huang PI, et al.Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma - derived CD44(+)ALDH1(+) cells. Mol Cancer Ther 2010; 9: 2879-92.
21. Huber GF, Albinger-Hegyi A, Soltermann A, et al.Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma. Cancer 2011; 117: 4659-70.
22. Häyry V, Mäkinen LK, Atula T, et al.Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue. Br J Cancer 2010; 102: 892-7.
23. World Health Organization. World Health Organization international histological classification of tumours. In: Pindborg JJ, Reichart PA, Smith CJ, Van der Waal I, eds. Histological typing of cancer and precancer of the oral mucosa. Berlin: Springer, 1997; 25-6.
24. Shi P, Liu W, Zhou ZT, He QB, Jiang WW. Podoplanin and ABCG2: malignant transformation risk markers for oral lichen planus. Cancer Epidemiol Biomarkers Prev 2010; 19: 844-9.
25. Visus C, Ito D, Amoscato A, et al.Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck. Cancer Res 2007; 67: 10538-45.
26. Liu W, Feng JQ, Shen XM, Wang HY, Liu Y, Zhou ZT. Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study. Cancer 2012; 118: 1693-700.
27. Smith J, Rattay T, McConkey C, Helliwell T, Mehanna H. Biomarkers in dysplasia of the oral cavity: a systematic review. Oral Oncol 2009; 45: 647-53.
28. Nankivell P, Mehanna H. Oral dysplasia: biomarkers, treatment, and follow-up. Curr Oncol Rep 2011; 13: 145-52.